Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF)
- Previous Close
1.2100 - Open
1.2100 - Bid --
- Ask --
- Day's Range
1.2100 - 1.2100 - 52 Week Range
1.2100 - 2.0750 - Volume
1,600 - Avg. Volume
1,412 - Market Cap (intraday)
8.16B - Beta (5Y Monthly) 0.25
- PE Ratio (TTM)
8.64 - EPS (TTM)
0.1400 - Earnings Date --
- Forward Dividend & Yield 0.08 (6.99%)
- Ex-Dividend Date Jul 18, 2023
- 1y Target Est
--
Shanghai Pharmaceuticals Holding Co., Ltd. engages research, development, manufacture, distribution, and retailing of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including digestive system, immune metabolism, motor neuron disease, endocrinology, cardiovascular, psychoneurotic, neoplasm, autoimmunity, systemic anti-infection, mental nerve, anti-tumor, oncology, respiratory system, nervous system, auto-immunity, hypertension, neuromyelitis, diabetes, anticholinesterase, polypeptide hormones uterine tonic, antihistamine, anti-inflammatory, anesthetic, immunomodulatory, antiviral, reflux esophagitis, analgesics, weight management, malignant peritoneal effusion, ulcerative colitis, myasthenia gravis, burn injury, anticoagulant, anti-epileptic, anticonvulsant, Alzheimer's, and inflammatory bowel diseases. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores. The company was incorporated in 1994 and is headquartered in Shanghai, China.
www.sphchina.com48,164
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: SHPMF
Performance Overview: SHPMF
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SHPMF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SHPMF
Valuation Measures
Market Cap
8.16B
Enterprise Value
8.88B
Trailing P/E
8.60
Forward P/E
6.69
PEG Ratio (5yr expected)
1.19
Price/Sales (ttm)
0.12
Price/Book (mrq)
0.47
Enterprise Value/Revenue
0.03
Enterprise Value/EBITDA
0.80
Financial Highlights
Profitability and Income Statement
Profit Margin
1.45%
Return on Assets (ttm)
2.61%
Return on Equity (ttm)
6.53%
Revenue (ttm)
260.3B
Net Income Avi to Common (ttm)
3.77B
Diluted EPS (ttm)
0.1400
Balance Sheet and Cash Flow
Total Cash (mrq)
40.67B
Total Debt/Equity (mrq)
64.63%
Levered Free Cash Flow (ttm)
-1.52B
Company Insights: SHPMF
SHPMF does not have Company Insights